OI
23
3
GILD
55
5
CLX
65
2
BEN
36
4
PRU
39
3
CPB
24
2
ICE
53
5
M
40
3
R
55
-2
INTU
54
2
HBI
53
4
PFG
27
7
DG
14
6
STT
48
4
PEP
33
4
NEM
30
2
ETN
64
4
ED
39
8
DOW
47
4
MHK
25
5
OI
23
3
GILD
55
5
CLX
65
2
BEN
36
4
PRU
39
3
CPB
24
2
ICE
53
5
M
40
3
R
55
-2
INTU
54
2
HBI
53
4
PFG
27
7
DG
14
6
STT
48
4
PEP
33
4
NEM
30
2
ETN
64
4
ED
39
8
DOW
47
4
MHK
25
5
Financhill
Back

Lowe's Companies 10K Form

Sell
42

LOW
Lowe's Companies

Last Price:
$247.67
Seasonality Move:
10.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LOW News And Ratings

See the #1 stock for the next 7 days that we like better than LOW

LOW Financial Statistics

Sales & Book Value

Annual Sales: $86.4B
Cash Flow: $728M
Price / Cash Flow: 18.07
Annual Sales: $-23.65
Price / Book: 0

Profitability

EPS (TTM): 11.99000
Net Income (TTM): $6.9B
Gross Margin: $28.8B
Return on Equity: 0%
Return on Assets: 15.62%

Lowe's Companies Earnings Forecast

Key Lowe's Companies Financial Ratios

  • The Gross Profit Margin over the past 41 years for LOW is 33.39%.
  • The Selling, General & Administrative Expenses for LOW have been equal to 18.03% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 19.19% of Operating Income.
  • The Net Earning history of LOW is 8.94% of Total Revenues.
  • Per Share Earnings over the last 41 years have been positive in 29 years.

Lowe's Companies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Specialty Retail
Sector: Consumer Discretionary
Current Symbol: LOW
CUSIP: 548661
Website: lowes.com

Debt

Debt-to-Equity Ratio: -2.64
Current Ratio: 1.13
Quick Ratio: 0.17

Price-to-Earnings

Trailing P/E Ratio: 18.77
Forward P/E Ratio: 19.82

LOW Technical Analysis vs Fundamental Analysis

Sell
42
Lowe's Companies (LOW) is a Sell

Is Lowe's Companies a Buy or a Sell?

  • Lowe's Companies stock is rated a Sell
    The current Lowe's Companies [LOW] share price is $247.72. The Score for LOW is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.